Conferences
ASTRO 2023: Stereotactic Ablative Radiotherapy Boost to Bladder Tumor for Bladder Preservation in Patients with Muscle-Invasive Bladder Cancer
October 1, 2023
ASTRO 2023: Outcomes of MR-Guided Stereotactic Body Radiotherapy for Adrenal Metastases: A Multi-Institutional Pooled Analysis
October 1, 2023
ASTRO 2023: Single Dose Compared to Fractionated High-Dose Rate Afterloading Brachytherapy in Localized Prostate Cancer: Long Term Results
October 1, 2023
IBCN 2023: Proteogenomic Characterization of Chemotherapy Response in Muscle Invasive Bladder Cancer
October 1, 2023
IBCN 2023: A Composite Biomarker Approach to Spare Neoadjuvant Chemotherapy in Select Muscle-Invasive Bladder Cancer Patients
October 1, 2023
IBCN 2023: Molecular Signatures Predict GEMDOCE Responses for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
October 1, 2023
IBCN 2023: Gene Expression-Based Classification of Urothelial Carcinoma For Research And Clinical Applications
October 1, 2023
IBCN 2023: Alignment Of Molecular Subtypes Across Multiple Bladder Cancer Subtyping Classifiers
October 1, 2023
IBCN 2023: Meta-Analysis of GWAS Data from Diverse Populations for Bladder Cancer (mapBC) Collaboration: Initial Findings
October 1, 2023